The pharmaceutical industry is called "five high" industries: the pharmaceutical market with high investment, high return, high risk, high technology and high management is an important factor to determine the talent demand of pharmaceutical enterprises. As China's medical reform has expanded the range of people who enjoy medical insurance, the overall pharmaceutical market will maintain steady growth from urban to rural areas, and the sales of pharmaceutical products will increase at a rate of about 8%~ 10%; The implementation of drug classification management system has made the drug retail industry have more space; The reform of medical and health institutions and the reform of drug circulation system require pharmaceutical enterprises to have a strong pharmaceutical marketing team, and require marketers to improve their own quality and adjust marketing strategies in time to meet the development needs of the pharmaceutical market. As far as specific fields are concerned, pharmaceutical commercial enterprises (pharmaceutical companies) are forming a good competitive mechanism in which enterprises of various ownership coexist and operate diversified markets. Pharmaceutical commercial enterprises have gradually realized diversified organizational structure and intensive management methods, and are breaking the restrictions of departments, regions and industries; The relevant departments of the state are planning and implementing total control in an all-round way, and its development trend is: the advantages of enterprise scale are outstanding; The OTC market is developing rapidly; The market radiation radius of commercial enterprises has greatly increased, and the distribution logistics and settlement system has been modernized.
Medical and health field: there are 65,438 hospitals at or above the county level+05,277 township health centers, 5,060 clinics, 233,000 outpatient departments and 503 sanatoriums in China. Most of the huge drug demand is in the field of drug retail supplied by drug marketers: there are a large number of drug retail pharmacies in China, and the OTC market value is more than 22 billion yuan. With the reform of China's medical system and the change of people's health concept, they seek medical advice. The way of self-purchasing drugs has also changed greatly, forming a trend. A research report of a company in Beijing on consumers' purchasing behavior and influencing factors in Guangzhou, Shanghai, Beijing and Wuhan shows that 79.6% of consumers have bought drugs in pharmacies. The market capacity of OTC drugs in China is increasing at the rate of 15% ~ 30% every year, and the market potential is huge.
big
Worry-free data in 2007 showed that in June +0 1, there were 8604 1 effective posts in the national pharmaceutical industry. Looking at the urban demand, Shanghai and Beijing are still ahead of the demand of first-tier cities, and the job demand is nearly four times more than that of Guangzhou and Shenzhen. Among the second-and third-tier cities, Jiangsu Province and Zhejiang Province are more prominent, among which Hangzhou, Suzhou and Nanjing have greater demand. In terms of enterprise type demand, there is a three-legged situation. The proportion of wholly foreign-owned enterprises, private enterprises and joint ventures is required to be 1: 1: 0.7. Among wholly foreign-owned enterprises, European and American enterprises account for more than 70%.
Except Beijing, Shanghai and Shanghai.
Outside the second-tier cities, the whole country
Demand in various places is relatively flat.
Both. This shows that medicine
Enterprise recruitment coverage
Quite extensive, the national demand is average.
It is full of vitality. Glen Pfizer
Sushi k and other large pharmaceutical companies.
The industry has launched a large-scale recruitment.
Plan to cover the whole country.
Dozens of cities, number of recruits
Hundreds of professionals.
There is a large-scale talent shortage in the pharmaceutical industry, and professionals believe that the reasons are complicated. First of all, pharmaceutical companies have been streamlining and merging in recent years, state-owned enterprises have been transforming, the demand for high-end jobs has soared, and staffing has turned to a market-oriented track; Secondly, in the past two years, private medicine has developed rapidly, foreign-funded enterprises have increased investment, and the demand for talents has continued to rise, making it difficult to cool down in a short time;
Third, with the reform of the medical system
In-depth, medicine gradually separated, which is straight.
Then it stimulated the demand for pharmaceutical marketing talents.
Seek; Finally, practitioners in the pharmaceutical industry
High turnover rate and frequent job hopping, resulting in
So that enterprises have to increase the talent pool.
It is also one of the factors of talent shortage in the industry.
One. We believe that the demand for talents in China pharmaceutical market is diversified in quantity, level and structure.
1. The demand for R&D marketing talents in the future is huge. Through the investigation of the above-mentioned manufacturers, we know that according to today's advanced production concept, the talent structure of most enterprises has the characteristics of "big at both ends and small in the middle", that is, the proportion of R&D and product marketing personnel is large and the proportion of production personnel is relatively small.
With the reform and standardization of a series of national medical systems and policies, the time when the market can be done well only by good sales policies has gradually left us. Instead, enterprises must also have products that are effective, safe, reliable and convenient for consumers as the strong backing of marketing.
Therefore, the pharmaceutical industry will have a greater demand for R&D talents with both medical theoretical knowledge and R&D skills. At the same time, with the scientific and technological progress of the pharmaceutical industry, the cycle of new products will be shorter and shorter in the future, and the requirements for marketing teams will be higher and higher. In the next few years, the primary task of pharmaceutical enterprises is to establish a stronger marketing team.
2. Enterprises need high-quality marketing talents. On the one hand, enterprises need a large number of marketing talents (ranking first in the demand for talents in various places for many years); On the other hand, although there are many people who are willing to engage in marketing in society, there are few marketing talents who really meet the requirements of pharmaceutical enterprises, which shows that the professional level, marketing ability and marketing concept of pharmaceutical marketers in China can not meet the actual needs of the market, and the shortage of marketing talents is essentially a shortage of quality.
3. Compound talents are favored by employers more and more, and now they have certain professional knowledge.
And marketing skills.
Capable compound talents are favored by pharmaceutical companies. Such talents should have certain professional knowledge of pharmacology, pharmacology, pharmaceutical production technology, product characteristics and so on, in order to better publicize products and win the broad trust of users. Therefore, the requirements of the pharmaceutical industry for pharmaceutical marketing talents are solid theory, skilled skills, rich experience, open-minded, practical and diligent, that is, they must be experts who know both medical professional knowledge and marketing skills.
No matter how many reasons pharmaceutical companies need talents.
Yuan believes that most pharmaceutical companies are short of people.
Technical personnel engaged in pharmaceutical sales and research and development. At present,
The biggest gap in the pharmaceutical industry is the position of pharmaceutical sales representative.
According to preliminary calculation, the future is worry-free 1 1 month.
The number of sales representatives exceeds one third of the total number of effective positions.
At present, the number of domestic pharmaceutical enterprises is huge, the total number
More than 4000, and because the pharmaceutical market is growing.
As well as the investment in new products of pharmaceutical enterprises and pharmaceutical marketing talents.
Demand continues to grow. However, under the huge demand of pharmaceutical sales talents, the requirements of pharmaceutical enterprises for sales personnel are more elite and professional. HR in the industry revealed to the author, "We not only have requirements for the professional academic background and relevant experience of medicine, but also pay attention to its ability and methods of handling things and solving problems". Obviously, paying equal attention to both soft and hard conditions of sales talents has become the leading direction of recruitment of pharmaceutical companies. However, the high demand for talent selection has also caused pharmaceutical companies to encounter recruitment bottlenecks. HR, a pharmaceutical company attending the job fair, lamented: "Enterprises dare not lower their requirements. After all, the sales representative is the core department of the enterprise, and we are willing to pay a high price and salary, but there are many onlookers, and few really dare to apply. Some people even doubt the integrity of the company. " Indeed, due to the severe form of the pharmaceutical industry in recent years, it is more difficult to sell pharmaceuticals, and it is difficult to complete the indicators. This position is not as attractive as before.
According to the research results of Taihe Consulting, the overall turnover rate of the pharmaceutical industry is 16.3%, slightly higher than last year's 15%. This is mainly caused by two reasons: on the one hand, the supply and demand of talents in key positions in the pharmaceutical industry continue to exceed demand, and the competition for talents is more intense; On the other hand, with the maturity of the pharmaceutical industry, the requirements for the ability of employees are constantly improving, which also increases the mobility of talents. From the perspective of departments, the mobility of sales department ranks first, while the turnover rate of human resources, finance and other functional sequences is relatively low. High-end marketing talents such as marketing managers and regional managers.
Management positions, the situation of poaching in the industry is more strict.
Heavy. According to industry sources, some sales departments
The high turnover rate is due to high wages and benefits and long training time.
A good medicine that is not worthy of commission and sale. After all,
Drugs with good sales volume have high commission and strong competition.
Force can also ease the working pressure of sales and get
A sense of accomplishment and satisfaction. As far as fresh blood is concerned,
It takes at least half a year to train fresh graduates to work smoothly.
After half a year, retaining talents will become the HR of the pharmaceutical industry.
Headache.
Judging from the current situation, the imbalance between supply and demand of talents is mainly caused by the differences in knowledge structure and ability and quality of talents. Compound talents that truly meet the needs of enterprises are very scarce and cannot meet the needs of employers.
Suggestions on personnel training
From the above analysis, it is not difficult to draw a conclusion: First, it is difficult to solve the talent shortage problem of pharmaceutical enterprises in China in a short time through their own efforts, so it is necessary to strengthen the cooperation between pharmaceutical production enterprises and vocational colleges and social vocational training institutions in colleges and universities, and build a vocational education chain with China characteristics.
Second, vocational colleges and social vocational training institutions should seize the opportunity of talent shortage in the pharmaceutical market.
speed up
The pace of higher education and vocational education reform should be organically combined with Industry-University-Research, so as to effectively meet the effective demand of society for high-level medical talents and realize the full employment of graduates from institutions of higher learning and vocational colleges.
Third, the government should strengthen the supervision of the pharmaceutical market and formulate a scientific and reasonable market access system for pharmaceutical marketing talents; Labor and social security departments should strengthen the professional qualification certification and professional qualification appraisal of pharmaceutical marketing talent groups, and accelerate the transformation of potential pharmaceutical talent resources into human resources.
In the field of R&D, due to the development trend of pharmaceutical business and the localization of scientific research in foreign-funded enterprises, pharmaceutical enterprises also have a tendency to flock to R&D technicians. A practitioner said, "In the past, many small and medium-sized enterprises in the pharmaceutical industry did not attach importance to R&D, and only relied on imitation to expand product increments and make sales terminals profitable. Although this model has a high short-term return, it is not a long-term solution. Especially with the changes in the market and the introduction of some policies, the research and development of new products has become the only way for enterprises to survive and develop. " According to the data of Taihe Consulting (a professional consulting organization), the salary of R&D technicians rose rapidly in 2007 compared with last year, with an increase of 26%. It also reflects that the out-of-stock of such talents should be based on the gradual establishment of a medical innovation system with enterprises as the main body, scientific research institutes as the support, market-oriented, products as the core and Industry-University-Research as the combination, and the research and development of new products by enterprises will play a central role. From the perspective of the whole industry, domestic pharmaceutical manufacturing enterprises generally lack the motivation of technological innovation, which will have a very adverse impact on the development of China's pharmaceutical manufacturing industry. In the confrontation with foreign pharmaceutical companies, it will fall behind. To reverse this situation, it is urgent to increase the investment and training of R&D technicians.
In addition to the research and development of new drugs, enterprises will also increase their efforts in environmental protection, energy conservation and emission reduction, energy management, comprehensive utilization of resources, etc., and employees in related fields will become the beacon of the pharmaceutical industry.
The demand for talents in the industry is fierce, and many pharmaceutical enterprises, especially large multinational and local enterprises, pay more and more attention to campus recruitment. However, the current recruitment situation is not optimistic, and many graduates with medical background are embarrassed about pharmaceutical companies. The high-paying position of medical representative is not the first choice for medical graduates.
According to statistics, the income of new doctors in Shanghai hospitals is generally around 1500 yuan. Although the medical representatives of pharmaceutical enterprises have higher income, doctors have stable income, high social status and professional counterparts.
The relationship between many.
Graduated from medical major
Industry students prefer it.
Start low.
In exchange for salary.
A stable
occupation
Although such as
Well, many companies.
Still shows that it will
Continue to expand the school
The power of garden recruitment
Degree. Related human resources
Express that the enterprise is willing to
It is intended to recruit qualified and potential graduates through campus recruitment, so as to cultivate new people and achieve the purpose of talent reserve and alleviating talent shortage. On the other hand, for the purpose of brand promotion, the influence of campus recruitment should not be underestimated.